Sun Yat-sen University: Lymphoma, B-Cell trials
The registry lists 11 Lymphoma, B-Cell studies with Sun Yat-sen University as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 7No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell LymphomaNot yet recruitingNCT07622784Phase 2
- Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell LymphomaRecruitingNCT07077512Phase 2
- Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBLRecruitingNCT06742502Phase 2
- A Prospective Study: Sintilimab and R-CHOP in PMBCL TreatmentNot yet recruitingNCT06412068Phase 2
- Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL PatientsRecruitingNCT05577364Phase 1/2
- A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP TherapyStatus unknownNCT05527912Phase 2
- DLBCL Treatment in Children and AdolescentsCompletedNCT04726995
- A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab EraStatus unknownNCT04624971
- Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell LymphomaStatus unknownNCT04423549
- Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHLStatus unknownNCT03245905Phase 2
- A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma PatientsStatus unknownNCT01793844